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Key questions
What is already known about this subject?
 ► Day case complex cardiac devices have been shown 
to be safe and are associated with increased patient 
satisfaction compared with overnight stay. Other 
medical fields have demonstrated cost savings 
when moving from overnight stay procedures to day 
case. Single-centre studies demonstrate that com-
plex cardiac devices are already being implanted in 
some centres.
What does this study add?
 ► This study demonstrates that the majority of hos-
pitals already implant complex cardiac devices as 
a day case to some extent. However, less than half 
of all patients having a complex cardiac device 
currently have this done as a day case procedure. 
There are significant cost savings to be made if a 
higher proportion of complex cardiac devices were 
implanted as a day case.
How might this impact on clinical practice?
 ► This sheds light on the current state of clinical prac-
tice in the UK and provides impetus to those centres 
which do not yet implant these devices as a day 
case. This study may encourage more day case pro-
cedures to be undertaken due to the resulting cost 
savings of up to £2169 per device compared with 
overnight stay.
AbstrAct
Objective Complex cardiac devices including 
implantable cardioverter defibrillator (ICD) and cardiac 
resynchronisation therapy (CRT) devices can safely 
be implanted as a day case procedure as opposed to 
overnight stay. We assess how common day case complex 
device therapy is and the cost implications of more 
widespread adoption across the UK.
Methods A freedom of information request was sent to all 
centres performing complex cardiac devices across the UK 
to assess the adoption of this technique. Cost implications 
were assessed using Department of Health National 
Schedule of Reference Costs 2016–2017.
Results 100 UK centres were surveyed, 80% replied. 
Eighty per cent of UK centres already implant complex 
cardiac devices as a day case to some extent. 64.06% 
of centres have a protocol for this. 12.82% of centres 
do <25% of complex devices as a day case. 15.38% do 
25%–50% as day case. 17.95% do 50%–75% as day 
case and 33.33% do >75% as day case. There was no 
relationship between centre volume and the proportion of 
devices done as a day case as opposed to overnight stay. 
The cost saving of performing a complex device as a day 
case as opposed to overnight stay was £412 per ICD, £525 
per CRT-pacemaker and £2169 per CRT-defibrillator.
Conclusions Day case complex devices are already 
widespread across the UK, however, there is scope for 
increase. An increase in proportion of day case devices 
could translate to £5 583 265 in savings annually for the 
National Health Service if all centres performed 75% of 
devices as a day case.
IntROduCtIOn
Simple permanent pacemakers have been 
implanted as day case procedures since the 
early 1980s,1 with the first UK day case pace-
maker being performed in 1989.2 Cost benefit 
studies have shown savings with same-day 
discharge compared with traditional overnight 
stay of between £203 and £430 per patient3 4. 
More recently, various centres have reported 
success in performing complex cardiac 
devices including implantable cardioverter 
defibrillator (ICD) and cardiac resynchroni-
sation therapy (CRT) as day cases, including 
improvements in patient satisfaction5 without 
compromising safety.5–8 These recent studies 
suggest that same-day discharge is becoming 
more widespread and increasingly seen as the 
standard of care, even though it is not advo-
cated in the current guidelines on complex 
cardiac devices. Here, we assess the situa-
tion across the UK with regard to same-day 
discharge following complex cardiac device 
insertion and examine the cost implications if 
these were to become routine practice across 
the country.
MetHOds
In order to assess the current UK-wide prac-
tice for complex cardiac device insertion, a 
list of all UK centres which implant cardiac 
devices was generated from the National Insti-
tute for Cardiovascular Outcomes Research 
(NICOR) National Audit of Cardiac Rhythm 
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Figure 1 Number of devices implanted by the centres we surveyed per year as of APRIL 2015 to March 2016 and their 
respective responses to FOI survey. Data from NICOR audit 2016.9 FOI, freedom of information.
Management Devices9 from 2015 to 2016. This includes 
both National Health Service (NHS) and private centres. 
Centres that do not implant complex devices, or those that 
implant less than 20 complex devices per year as well as 
paediatric centres, were excluded. A survey was sent to all 
remaining UK centres which perform complex cardiac 
devices as per the Freedom of Information Act, 2000.
The survey was comprised of the following questions:
1. Does your hospital perform complex cardiac devic-
es as a day case procedure? This includes ICD, CRT-
pacemaker and defibrillator (CRT-P and CRT-D).
2. If so, do you have a trust protocol for this procedure?
3. What proportion of complex pacing is done as day 
case as compared with overnight stay: <25% day case, 
25%–50% day case, 50%–75% day case or >75% day 
case?
We assessed the costs of implanting each of the three 
different devices (ICD, CRT-P and CRT-D) when performed 
as both day case as well as with an inpatient stay. These data 
were obtained by using the Department of Health National 
Schedule of Reference Costs 2016–2017.10 We opted for 
this as it is a more representative estimation of the true cost 
of the procedures to the NHS, rather than a tariff, which 
would be the amount paid to a trust by the government on 
insertion of a device. The reference cost data give an upper 
and lower quartile price as well as the national average. We 
used the national average in all cases. This data allowed us 
to compare the cost difference between an inpatient stay 
and a day case procedure. Statistical analysis of differences 
between responses was assessed using the χ2 test.
Results
Of the 198 centres identified from the NICOR audit, 64 
were excluded as they do not perform complex cardiac 
devices (n=60) or were paediatric centres (n=4). A 
further 34 centres were excluded as they implant less 
than 20 complex cardiac devices per year. We sent the 
survey to the remaining 100 centres. Of these 100 centres, 
the number of complex devices inserted per year ranged 
from 20 to 639 with a mean of 135. The centres are shown 
below in by volume according to the NICOR audit as well 
as their responses to our survey (figure 1).9
Of the surveyed centres, we received responses to the 
freedom of information (FOI) requests from 80 (80%) of 
the 100 centres. Sixty-four centres (64%) stated that they 
already implant complex cardiac devices as a day case: 
41 (41%) centres perform complex pacing as a day case 
and have a protocol for the procedure as part of the trust 
policy. Twenty-three (23%) centres perform complex 
pacing as day case but do not have a protocol for this 
(figure 2).
When asked what proportion of their complex devices 
are done as a day case as compared with overnight stay, 
two centres were unable to give this information. These 
were excluded for further evaluation. The proportion of 
complex devices done as a day case from the remaining 
centres was as follows. Sixteen centres (20.51%) do not 
perform any complex devices as a day case. Ten centres 
(12.82%) do <25% as day case. Twelve centres (15.38%) 
do 25%–50% as day case. Fourteen centres (17.95%) do 
50%–75% as day case and 26 centres (33.33%) do >75% 
as day case (figure 3)
We analysed the total number complex devices that 
these respective quintiles implant per year; those doing 
<25% as day case implant 1492. Those doing 25%–50% 
implant 1922. Those doing 50%–75% implant 2316 and 
those doing >75% as day case implant 3582 per year. 
Additionally, those centres which do not do any complex 
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Figure 2 Proportion of centres which responded to FOI 
Request, and how many perform complex pacing as a day 
case and have a protocol. FOI, freedom of information.
Figure 3 Proportion of complex devices done as day case.
devices as a day case amount to 2158 devices per year 
(figure 4).
To investigate the relationship between centre volume 
and the proportion of devices implanted as a day case, we 
divided the centres into quartiles by number of complex 
devices inserted annually—Q1 (<50 devices per year), Q2 
(51–93 devices per year), Q3 (94–193 devices per year) 
and Q4 (>193 devices per year). The results of this are 
demonstrated below in figure 5. There was no difference 
in proportion of day case devices versus overnight devices 
between the different volume centres.
Although not included in the questionnaire, three 
centres were able to give a breakdown of the proportion 
of each complex device (ICD, CRT-P and CRT-D) which 
are implanted as a day case. On average, 75% of ICDs, 
30% of CRT-P devices and 25% of CRT-D devices are 
implanted as a day case in these centres (figure 6).
We looked at the cost difference between complex 
cardiac devices which are inserted as a day case as 
compared with an overnight stay. Table 1 demonstrates 
the national reference costs for these, including ICD, 
CRT-P and CRT-D.10 The saving associated with a day case 
procedure as opposed to an overnight stay is demon-
strated on the right of the table.
dIsCussIOn
As a practice, day case complex cardiac devices are already 
widespread across the UK, but to varying degrees. Eighty 
per cent of centres which responded to our FOI request 
already perform day case complex cardiac devices to some 
extent. Where centres do perform complex devices as a 
day case, there is a trend towards doing a high propor-
tion of all devices as a day case rather than an overnight 
stay. However, based on responses, as a total proportion 
of all complex devices inserted in the UK, less than half 
are currently being implanted as a day case. There does 
not seem to be any relationship between the volume of 
complex devices inserted annually and the proportion 
which are done as a day case, that is, high volume centres 
do not particularly seem to be performing a large number 
of day case procedures.
There are great potential savings to be made in 
switching from overnight procedures to day case. This has 
been demonstrated in many fields of medical practice, 
with a strong evidence base, particularly in the surgical 
specialties.11–13 Day case complex cardiac devices can save 
between £412 (for ICD) and £2169 (CRT-D) per device. 
From our data, we can estimate the total proportion of 
complex devices which are implanted as a day case in the 
UK from the centres surveyed. Assuming that each centre 
does half the quartile range as a day case procedure (ie, 
12.5% for those doing <25% as day case, 37.5% for those 
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Figure 4 Total number of complex devices inserted per year by proportion done as day case.
Figure 5 Proportion of devices inserted as day case by volume of centre.
doing 25%–50%, etc), 47.86% of all complex cardiac 
devices are being inserted as a day case annually in the 
UK. Every year the European Heart Rhythm Association 
produces a document called ‘The White Book’ which 
surveys and records the total number of complex cardiac 
devices inserted annually in each European Society of 
Cardiology member country.14 In the UK, in 2016, there 
were 7242 ICD insertions, 4318 CRT-P insertions and 
7063 CRT-D insertions in total,14 making a total of 18 
623 complex devices inserted per year. If the proportion 
of devices being implanted as a day case increased from 
the current 47.86% so that each centre was achieving 
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Figure 6 Proportion of each type of complex device inserted as a day case (n=3). CRT-D, cardiac resynchronisation therapy-
defibrillator; CRT-P, cardiac resynchronisation therapy-pacemaker; ICD, implantable cardioverter defibrillator.
Table 1 Costs of implanting complex devices as day case, 
overnight stay and day case saving10
Procedure Day case Overnight
Day case 
saving
ICD £4792 £5204 £412
CRT-P £3622 £4147 £525
CRT-D £6530 £8699 £2169
CRT-D, cardiac resynchronisation therapy-defibrillator; CRT-P, 
cardiac resynchronisation therapy-pacemaker; ICD, implantable 
cardioverter defibrillator.
the highest quartile (75% as day case), then this would 
change the total number of devices being inserted as a 
day case from 8913 to 13 967 or an extra 5054 devices per 
year. Given the current split between the three complex 
devices, this would equate to a saving of £5 583 265 per 
year across the UK (table 2). It would likely also improve 
the patient experience and freeing up beds for other 
patients.
This study has some limitations which should be 
addressed in combination with its conclusions. We used 
an FOI request to gain data around the current state 
of day case complex devices across the UK at present. 
This limited the detail of the questions asked in order 
to reduce the time centres required to formulate a 
response. Furthermore, there was a significant non-re-
sponse rate. Non-responders were contacted at serial 
points throughout the study and the final non-responder 
rate was 20%. Non-responding centres did not appear 
to be different from responders in terms of volume of 
complex devices done per year, therefore, this is unlikely 
to be a major factor.
The data include feedback from private hospitals, which 
were not obliged to respond to the FOI request and also 
are not reimbursed in the same way that the NHS centres 
are, therefore, our results are only applicable to the NHS. 
Also, there is inherent error in assuming the midpoint 
of the quartile range to estimate the number of devices 
implanted as a day case per year. Another issue is the 
limited feedback on the split between ICD, CRT-P and 
CRT-D as daycase procedures. A small number of centres 
were able to give us this information and as expected, 
the greater the complexity of the procedure, the more 
likely it was to be done as an overnight stay with three 
quarters of ICDs but only one-quarter of CRT-D devices 
being inserted as a day case procedure. It is possible that 
if certain centres implant more ICDs compared with CRT 
devices, this may partly explain the discrepancy in day 
case proportions between centres.
Potential barriers to more widespread application of 
day case complex cardiac devices include the following. 
Some cardiologists may feel that a day case complex 
device is less safe than when a patient can be observed 
overnight or associated with a higher readmission rate. 
This has been shown not to be the case with several 
papers demonstrating no increase in complications with 
same-day discharge of patients having complex cardiac 
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Table 2 Projected cost savings by increasing day case procedures from current projection (47.86%) to 75%10 15
Procedure
Number per 
year
Current daycase 
(47.86%)
Ideal target 
(75%)
Extra devices 
per year
Saving per 
device
Total saving per 
year
ICD 7242 3466 5432 1966 £412 £809 992
CRT-P 4318 2067 3239 1172 £525 £615 300
CRT-D 7063 3380 5297 1917 £2169 £4 157 973
Total  £5 583 265
CRT-D, cardiac resynchronisation therapy-defibrillator; CRT-P, cardiac resynchronisation therapy-pacemaker; ICD, implantable cardioverter 
defibrillator.
devices over a 6-week follow-up period.5 15 These papers 
are single-centre experiences, however, it is difficult to 
envisage how complication rates would vary significantly 
across the country. Some patients may not like the idea 
of being discharged after a complex procedure such 
as a CRT-D. However, it has been shown that same-day 
discharge following CRT is associated with higher satis-
faction from patients compared with overnight stay.5
Widespread adoption of day case as the standard of care 
for insertion of complex devices will have implications 
of list organisation and will require a defined protocol 
in order to ensure patient safety and efficiency. In our 
study, 66% of centres performing day case complex 
devices had a protocol. We received an example protocol 
from three of the surveyed hospitals. There was discrep-
ancy between these protocols in terms of the timing of 
the postimplant chest X-ray and device check and also 
the duration of observation prior to discharge—varying 
from 90 min to 4 hours postprocedure. An example of 
the protocol created at our trust is included in supple-
ment A. Predischarge protocol includes a device check 
as well as a chest X-ray to assess lead position and, in the 
case of axillary or subclavian access, exclusion of pneu-
mothorax. These need to be performed in time for them 
to be appropriately checked and the patient discharged. 
This means that it is likely that patients undergoing day 
case complex devices will need to be done earlier in the 
day than had they been planned for an overnight stay. A 
potential solution to this is using cephalic-only access as 
has been reported to be safe and effective.16 17
On the whole, overcoming these barriers is a surmount-
able challenge that should lead to both clinical and finan-
cial benefit in the field of complex devices.
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